Back to Results
First PageMeta Content
Health / Angiology / Emerging technologies / Macular degeneration / Vascular endothelial growth factor / Biotechnology / Advanced Cell Technology / Ranibizumab / Drusen / Biology / Medicine / Stem cells


Document Date: 2014-12-01 00:40:30

Open Document

File Size: 252,57 KB

Share Result on Facebook

City

Perth / /

Company

Foundation Ambassador and son / Drusen Photoreceptors RPE Bruch / AMD / /

Continent

Europe / /

Country

Switzerland / Germany / Japan / United States / Australia / United Kingdom / Denmark / /

Currency

USD / /

Event

FDA Phase / Person Communication and Meetings / /

Facility

University College London / Penn State College of Medicine / Sydney Opera House / /

IndustryTerm

manufacturing dossier / low energy / manufacturing process / energy / Waste products / toxic waste products / digested food / /

MedicalCondition

particular disease / wet macular degeneration / macular degeneration / very complex disease / age-related macular degeneration / Stargardt’s disease / serious diseases / cancer / disease / early macular degeneration / why macular degeneration / diseases / dry macular degeneration / earlier stage disease / inflammation / /

MedicalTreatment

radiation / Gene therapy / laser treatment / /

Organization

Pharmaceutical Benefits Advisory Committee / University College London / Therapeutic Goods Administration / Macular Disease Foundation Australia / FDA / College of Medicine / National Health & Medical Research Council / /

Person

Shinya Yamanaka / Jan Utzon / Safety / Jørn Utzon / /

/

Position

eye specialist / optometrist / Governor General / designer / Ambassador / /

Product

Lucentis / Choroid If waste products / Choroid If / AMD / /

ProvinceOrState

Maryland / /

Technology

radiation / X-ray / Stem cells / Gene therapy / laser / /

URL

www.mdfoundation.com.au / /

SocialTag